209 related articles for article (PubMed ID: 20639458)
1. A combination of hypoxia and lipopolysaccharide activates tristetraprolin to destabilize proinflammatory mRNAs such as tumor necrosis factor-alpha.
Werno C; Schmid T; Schnitzer SE; Peters K; Milke L; Brüne B
Am J Pathol; 2010 Sep; 177(3):1104-12. PubMed ID: 20639458
[TBL] [Abstract][Full Text] [Related]
2. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.
Hitti E; Iakovleva T; Brook M; Deppenmeier S; Gruber AD; Radzioch D; Clark AR; Blackshear PJ; Kotlyarov A; Gaestel M
Mol Cell Biol; 2006 Mar; 26(6):2399-407. PubMed ID: 16508014
[TBL] [Abstract][Full Text] [Related]
3. Activation of liver X receptors promotes inflammatory cytokine mRNA degradation by upregulation of tristetraprolin.
Xiao J; Chen Q; Tang D; Ou W; Wang J; Mo Z; Tang C; Peng L; Wang D
Acta Biochim Biophys Sin (Shanghai); 2017 Mar; 49(3):277-283. PubMed ID: 28119310
[TBL] [Abstract][Full Text] [Related]
4. Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways.
Deleault KM; Skinner SJ; Brooks SA
Mol Immunol; 2008 Jan; 45(1):13-24. PubMed ID: 17606294
[TBL] [Abstract][Full Text] [Related]
5. Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA.
Sun L; Stoecklin G; Van Way S; Hinkovska-Galcheva V; Guo RF; Anderson P; Shanley TP
J Biol Chem; 2007 Feb; 282(6):3766-77. PubMed ID: 17170118
[TBL] [Abstract][Full Text] [Related]
6. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability.
Mahtani KR; Brook M; Dean JL; Sully G; Saklatvala J; Clark AR
Mol Cell Biol; 2001 Oct; 21(19):6461-9. PubMed ID: 11533235
[TBL] [Abstract][Full Text] [Related]
7. LPS-induced production of TNF-α and IL-6 in mast cells is dependent on p38 but independent of TTP.
Hochdörfer T; Tiedje C; Stumpo DJ; Blackshear PJ; Gaestel M; Huber M
Cell Signal; 2013 Jun; 25(6):1339-47. PubMed ID: 23499908
[TBL] [Abstract][Full Text] [Related]
8. The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself.
Tchen CR; Brook M; Saklatvala J; Clark AR
J Biol Chem; 2004 Jul; 279(31):32393-400. PubMed ID: 15187092
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide regulation of antiinflammatory tristetraprolin family and proinflammatory gene expression in mouse macrophages.
Cao H
BMC Res Notes; 2024 Mar; 17(1):82. PubMed ID: 38504371
[TBL] [Abstract][Full Text] [Related]
10. NADPH oxidase-derived superoxide destabilizes lipopolysaccharide-induced interleukin 8 mRNA via p38, extracellular signal-regulated kinase mitogen-activated protein kinase, and the destabilizing factor tristetraprolin.
Al Ghouleh I; Magder S
Shock; 2012 Apr; 37(4):433-40. PubMed ID: 22392142
[TBL] [Abstract][Full Text] [Related]
11. Cullin 4B is recruited to tristetraprolin-containing messenger ribonucleoproteins and regulates TNF-α mRNA polysome loading.
Pfeiffer JR; Brooks SA
J Immunol; 2012 Feb; 188(4):1828-39. PubMed ID: 22262661
[TBL] [Abstract][Full Text] [Related]
12. Compounds that increase or mimic cyclic adenosine monophosphate enhance tristetraprolin degradation in lipopolysaccharide-treated murine j774 macrophages.
Jalonen U; Paukkeri EL; Moilanen E
J Pharmacol Exp Ther; 2008 Aug; 326(2):514-22. PubMed ID: 18469159
[TBL] [Abstract][Full Text] [Related]
13. miR-346 controls release of TNF-α protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization.
Semaan N; Frenzel L; Alsaleh G; Suffert G; Gottenberg JE; Sibilia J; Pfeffer S; Wachsmann D
PLoS One; 2011; 6(5):e19827. PubMed ID: 21611196
[TBL] [Abstract][Full Text] [Related]
14. CARHSP1 is required for effective tumor necrosis factor alpha mRNA stabilization and localizes to processing bodies and exosomes.
Pfeiffer JR; McAvoy BL; Fecteau RE; Deleault KM; Brooks SA
Mol Cell Biol; 2011 Jan; 31(2):277-86. PubMed ID: 21078874
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tristetraprolin deadenylation by poly(A) binding protein.
Rowlett RM; Chrestensen CA; Schroeder MJ; Harp MG; Pelo JW; Shabanowitz J; DeRose R; Hunt DF; Sturgill TW; Worthington MT
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G421-30. PubMed ID: 18467502
[TBL] [Abstract][Full Text] [Related]
16. Tristetraprolin mediates anti-inflammatory effects of nicotine in lipopolysaccharide-stimulated macrophages.
Joe Y; Kim HJ; Kim S; Chung J; Ko MS; Lee WH; Chang KC; Park JW; Chung HT
J Biol Chem; 2011 Jul; 286(28):24735-42. PubMed ID: 21606497
[TBL] [Abstract][Full Text] [Related]
17. Tristetraprolin (TTP) coordinately regulates primary and secondary cellular responses to proinflammatory stimuli.
Qiu LQ; Lai WS; Bradbury A; Zeldin DC; Blackshear PJ
J Leukoc Biol; 2015 Apr; 97(4):723-36. PubMed ID: 25657290
[TBL] [Abstract][Full Text] [Related]
18. PARP-14 combines with tristetraprolin in the selective posttranscriptional control of macrophage tissue factor expression.
Iqbal MB; Johns M; Cao J; Liu Y; Yu SC; Hyde GD; Laffan MA; Marchese FP; Cho SH; Clark AR; Gavins FN; Woollard KJ; Blackshear PJ; Mackman N; Dean JL; Boothby M; Haskard DO
Blood; 2014 Dec; 124(24):3646-55. PubMed ID: 25293769
[TBL] [Abstract][Full Text] [Related]
19. 3'UTR AU-Rich Elements (AREs) and the RNA-Binding Protein Tristetraprolin (TTP) Are Not Required for the LPS-Mediated Destabilization of Phospholipase-Cβ-2 mRNA in Murine Macrophages.
Shukla S; Elson G; Blackshear PJ; Lutz CS; Leibovich SJ
Inflammation; 2017 Apr; 40(2):645-656. PubMed ID: 28124257
[TBL] [Abstract][Full Text] [Related]
20. Hypothemycin inhibits tumor necrosis factor-α production by tristetraprolin-dependent down-regulation of mRNA stability in lipopolysaccharide-stimulated macrophages.
Park KH; Yoon YD; Kang MR; Yun J; Oh SJ; Lee CW; Lee MY; Han SB; Kim Y; Kang JS
Int Immunopharmacol; 2015 Dec; 29(2):863-868. PubMed ID: 26371861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
